These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3524050)
81. [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old]. Grigor'eva EP; Rekstin AR; Rudenko LG; Ramirez A; Barro M; Lisovskaia KV; Klimov AI; Aleksandrova GI Vopr Virusol; 1994; 39(1):26-9. PubMed ID: 8160445 [TBL] [Abstract][Full Text] [Related]
82. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. Cha TA; Kao K; Zhao J; Fast PE; Mendelman PM; Arvin A J Clin Microbiol; 2000 Feb; 38(2):839-45. PubMed ID: 10655394 [TBL] [Abstract][Full Text] [Related]
83. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. Steinhoff MC; Halsey NA; Fries LF; Wilson MH; King J; Burns BA; Samorodin RK; Perkis V; Murphy BR; Clements ML J Infect Dis; 1991 May; 163(5):1023-8. PubMed ID: 2019751 [TBL] [Abstract][Full Text] [Related]
84. Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Lazar A; Okabe N; Wright PF Infect Immun; 1980 Mar; 27(3):862-6. PubMed ID: 6155338 [TBL] [Abstract][Full Text] [Related]
85. [The results of state trials of inactivated influenza vaccines for children]. Vasil'eva RI; Smirnova LA; Rudenko LG; Drinevskiĭ VP; Tsaritsina IM Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):49-54. PubMed ID: 2968738 [TBL] [Abstract][Full Text] [Related]
86. [Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime]. Vasil'eva RI; Liamtseva GA; Riazantseva TG; Oleĭnikova EV; Sosunov AV Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):10-4. PubMed ID: 2939666 [TBL] [Abstract][Full Text] [Related]
87. [Results of a study of new preparations of inactivated whole-virion influenza vaccines for the protection of children in the USSR]. Vasil'eva RI; Lonskaia NI; Nefedova LA; Iaroshevskaia IIu; Bichurina MA Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):38-42. PubMed ID: 3591124 [TBL] [Abstract][Full Text] [Related]
88. Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children. Anderson EL; Newman FK; Maassab HF; Belshe RB J Clin Microbiol; 1992 Sep; 30(9):2230-4. PubMed ID: 1400985 [TBL] [Abstract][Full Text] [Related]
89. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. Clements ML; Betts RF; Tierney EL; Murphy BR J Clin Microbiol; 1986 Jan; 23(1):73-6. PubMed ID: 3700611 [TBL] [Abstract][Full Text] [Related]
90. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. Karron RA; Steinhoff MC; Subbarao EK; Wilson MH; Macleod K; Clements ML; Fries LF; Murphy BR Pediatr Infect Dis J; 1995 Jan; 14(1):10-6. PubMed ID: 7715982 [TBL] [Abstract][Full Text] [Related]
91. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. Steinhoff MC; Fries LF; Karron RA; Clements ML; Murphy BR J Clin Microbiol; 1993 Apr; 31(4):836-8. PubMed ID: 8463393 [TBL] [Abstract][Full Text] [Related]
92. Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Kendal AP Eur J Epidemiol; 1997 Jul; 13(5):591-609. PubMed ID: 9258574 [TBL] [Abstract][Full Text] [Related]
93. The role of live influenza vaccines in children. Gruber WC Vaccine; 2002 May; 20 Suppl 2():S66-73. PubMed ID: 12110263 [TBL] [Abstract][Full Text] [Related]
94. The development of live attenuated cold-adapted influenza virus vaccine for humans. Maassab HF; Bryant ML Rev Med Virol; 1999; 9(4):237-44. PubMed ID: 10578119 [TBL] [Abstract][Full Text] [Related]
95. Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine. Clements ML; Tierney EL; Murphy BR J Clin Microbiol; 1985 Jun; 21(6):997-9. PubMed ID: 4008629 [TBL] [Abstract][Full Text] [Related]
96. Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Slepushkin AN; Obrosova-Serova NP; Burtseva EI; Rudenko LG; Govorkova EA; Vartanyan RV; Verestsinsky AI; Lonskaya NI; Harmon MW; Torok T Vaccine; 1993; 11(3):323-8. PubMed ID: 8447161 [TBL] [Abstract][Full Text] [Related]
97. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Longini IM; Halloran ME; Nizam A; Wolff M; Mendelman PM; Fast PE; Belshe RB Vaccine; 2000 Mar; 18(18):1902-9. PubMed ID: 10699339 [TBL] [Abstract][Full Text] [Related]
98. [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old]. Rudenko LG; Grigor'eva EP; Drinevskiĭ VP; Koval' TA; Doroshenko EM Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):41-6. PubMed ID: 2970743 [TBL] [Abstract][Full Text] [Related]
99. [COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES]. Markushin SG; Tsfasman TM; Terekhov AV; Lisovskaya KV; Akopova II Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):27-32. PubMed ID: 26829850 [TBL] [Abstract][Full Text] [Related]
100. [Comparative study of the effectiveness of inactivated influenza vaccine preparations]. Ismagulov AT; Nurgaliev KN Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):84-7. PubMed ID: 6880484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]